MIT Sloan MBA Class Of 2027: International Ranks Grow, But U.S. Diversity Stays Flat

The MIT Sloan School of Management enrolled 450 students in its MBA Class of 2027, its second-largest class in nearly a ...

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

Optigo Biotherapeutics (“Optigo”), an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas Wallnöfer is joining its ...